Your browser doesn't support javascript.
loading
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Denham, James W; Joseph, David; Lamb, David S; Spry, Nigel A; Duchesne, Gillian; Matthews, John; Atkinson, Chris; Tai, Keen-Hun; Christie, David; Kenny, Lizbeth; Turner, Sandra; Gogna, Nirdosh Kumar; Diamond, Terry; Delahunt, Brett; Oldmeadow, Chris; Attia, John; Steigler, Allison.
Afiliação
  • Denham JW; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia. Electronic address: jim.denham@newcastle.edu.au.
  • Joseph D; Sir Charles Gairdner Hospital, Perth, WA, Australia; Department of Medicine and Surgery, University of Western Australia, Perth, WA, Australia.
  • Lamb DS; Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand.
  • Spry NA; Sir Charles Gairdner Hospital, Perth, WA, Australia.
  • Duchesne G; Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia.
  • Matthews J; Auckland City Hospital, Auckland, New Zealand.
  • Atkinson C; St Georges Cancer Care Centre, Christchurch, New Zealand.
  • Tai KH; Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia.
  • Christie D; Genesiscare, Tugun, QLD, Australia.
  • Kenny L; Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia; School of Medicine, University of Queensland, QLD, Australia.
  • Turner S; Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, NSW, Australia.
  • Gogna NK; Mater Radiation Oncology Centre, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Diamond T; St George Hospital, Department of Endocrinology, Kogarah, NSW, Australia.
  • Delahunt B; Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand.
  • Oldmeadow C; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, Newcastle, NSW, Australia.
  • Attia J; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, Newcastle, NSW, Australia.
  • Steigler A; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
Lancet Oncol ; 20(2): 267-281, 2019 02.
Article em En | MEDLINE | ID: mdl-30579763
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata / Tratamento / Radioterapia Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Braquiterapia / Ácido Zoledrônico / Antagonistas de Androgênios Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata / Tratamento / Radioterapia Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Braquiterapia / Ácido Zoledrônico / Antagonistas de Androgênios Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article